NSN 6505-01-340-4829 of Clonazepam Tablets - Product Details
Just NSN Parts, owned and operated by ASAP Semiconductor, is an industry-leading distributor of NSN 6505-01-340-4829 parts applicable in the aviation and defense industries. We aim to simplify the NSN 6505-01-340-4829 parts procurement process by enabling our customers to search through our inventory quickly and efficiently. Type in your desired NSN 6505-01-340-4829 part number such as NDC60505-0067-01, NDC57664-0274-08, NDC51079-0882-21, NDC51079-0882-01, NDC00904-5343-60 into our search engine and, in a matter of seconds, available stock will appear.
We pride ourselves on our attention to detail and focus on quality control. We are FAA AC 0056B accredited and AS9120B, ISO 9001:2015 certified. We offer our customers a personalized and reliable service that will change your parts procurement process. If you would like to receive a quote today, fill out a request for quote form today.
Alternative NSN: 6505-01-340-4829 |
Item Name:Clonazepam Tablets |
NIIN: 013404829 |
NCB Code: USA (01) |
Manufacturers: Falcon Pharmaceuticals Ltd , Caraco Pharmaceutical Laboratories , Mylan Institutional Llc , Major Pharmaceuticals Llc , Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Actavis Inc , Sandoz Inc , Eon Labs Llc , Goldline Laboratories Inc , Lemmon Co , Hoffmann La Roche Ltd |
Manufacturer's List for NSN 6505-01-340-4829, 6505013404829
Part Number Related To NSN 6505-01-340-4829, 6505013404829
Part No | NSN | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC60505-0067-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC57664-0274-08 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC51079-0882-21 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC51079-0882-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00904-5343-60 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00591-0747-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00378-1912-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00228-3004-11 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00185-0064-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00185-0064-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00182-8229-89 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00093-0833-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
NDC00004-0058-01 | 6505-01-340-4829 | clonazepam tablets | Avl | RFQ |
Characteristics Data of NSN 6505013404829
MRC | Criteria | Characteristic |
---|---|---|
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 1MG I.S. 100S PG |
FEAT | SPECIAL FEATURES | UNIT DOSE; REVERSE NUMBER PACK |
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 25.000 TABLETS |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 4 |
CQCT | PRIMARY CONTAINER TYPE | STRIP,REVERSE NUMBERED |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |